title: Involvement of DNA topoisomerase IIbeta in neuronal differentiation.
abstract: Two isoforms of DNA topoisomerase II (topo II) have been identified in mammalian cells. While topo IIalpha is essential for chromosome segregation in mitotic cells, in vivo function of topo IIbeta remains to be clarified. Here we demonstrate that the nucleoplasmic topo IIbeta, highly expressed in differentiating cerebellar neurons, is the catalytically competent entity operating directly on chromatin DNA in vivo. When the cells reached terminal differentiation, this in vivo activity decreased to a negligible level with concomitant loss of the nucleoplasmic enzyme. Effects of topo II-specific inhibitors were analyzed in a primary culture of cerebellar granule neurons that can mimic the in vivo situation. Only the beta isoform was expressed in granule cells differentiating in vitro. ICRF-193, a catalytic topo II inhibitor, suppressed the transcriptional induction of amphiphysin I which is essential for mature neuronal activity. The effect decreased significantly as the cells differentiate. Expression profiling with a cDNA macroarray showed that 18% of detectable transcripts were up-regulated during the differentiation and one-third of them were susceptible to ICRF-193. The results suggest that topo IIbeta is involved in an early stage of granule cell differentiation by potentiating inducible neuronal genes to become transcribable probably through alterations in higher order chromatin structure.
authors: Department of Molecular Biology, Institute of Cellular and Molecular Biology, Okayama University Medical School, Okayama 700-8558, Japan. tsukken@cc.okayama-u.ac.jp
authors: K
authors: K
authors: Tsutsui
authors: K
authors: K
authors: Tsutsui
authors: K
authors: K
authors: Sano
authors: A
authors: A
authors: Kikuchi
authors: A
authors: A
authors: Tokunaga
mesh_terms: D000818:Animals; D000831:Animals, Newborn; D002454:Cell Differentiation; D002467:Cell Nucleus / Q000201:enzymology; D002525:Cerebellar Cortex / Q000166:cytology* / Q000201:enzymology / Q000254:growth & development; D004250:DNA Topoisomerases, Type II / Q000302:isolation & purification / Q000378:metabolism*; D004268:DNA-Binding Proteins / Q000302:isolation & purification / Q000378:metabolism; D054659:Diketopiperazines; D005047:Etoposide / Q000494:pharmacology; D005786:Gene Expression Regulation; D007527:Isoenzymes / Q000302:isolation & purification / Q000378:metabolism; D008297:Male; D009419:Nerve Tissue Proteins / Q000096:biosynthesis; D009474:Neurons / Q000166:cytology* / Q000378:metabolism; D010879:Piperazines / Q000494:pharmacology; D012333:RNA, Messenger / Q000378:metabolism; D051381:Rats; D017208:Rats, Wistar; D059005:Topoisomerase II Inhibitors
chemical_list: D004268:DNA-Binding Proteins; D054659:Diketopiperazines; D007527:Isoenzymes; D009419:Nerve Tissue Proteins; D010879:Piperazines; D012333:RNA, Messenger; D059005:Topoisomerase II Inhibitors; C075637:amphiphysin; C070899:4,4'-(1,2-dimethyl-1,2-ethanediyl)bis-2,6-piperazinedione; D005047:Etoposide; D004250:DNA Topoisomerases, Type II